Pages that link to "Q43609643"

The following pages link to Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate (Q43609643):

Displaying 40 items.

• Characterization of the in vitro kinetic interaction of chlorpyrifos-oxon with rat salivary cholinesterase: a potential biomonitoring matrix (Q23909381) (← links)
• Physiologically based pharmacokinetic modeling for 1-bromopropane in F344 rats using gas uptake inhalation experiments (Q23910662) (← links)
• Development of a physiologically based pharmacokinetic and pharmacodynamic model to determine dosimetry and cholinesterase inhibition for a binary mixture of chlorpyrifos and diazinon in the rat (Q23910753) (← links)
• Noninvasive biomonitoring approaches to determine dosimetry and risk following acute chemical exposure: analysis of lead or organophosphate insecticide in saliva (Q23911010) (← links)
• An age-dependent physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus insecticide chlorpyrifos in the preweanling rat (Q23911011) (← links)
• Comparative chlorpyrifos pharmacokinetics via multiple routes of exposure and vehicles of administration in the adult rat (Q23915379) (← links)
• Physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus pesticide diazinon (Q23922265) (← links)
• Physiologically based pharmacokinetic modeling of organophosphorus and carbamate pesticides (Q25892170) (← links)
• Developing a Physiologically-Based Pharmacokinetic Model Knowledgebase in Support of Provisional Model Construction (Q28550166) (← links)
• A physiologically based pharmacokinetic model for the oxime TMB-4: simulation of rodent and human data. (Q30585790) (← links)
• Prediction of in vivo tissue distribution from in vitro data 1. Experiments with markers of aqueous spaces (Q30608992) (← links)
• Physicochemical and biological data for the development of predictive organophosphorus pesticide QSARs and PBPK/PD models for human risk assessment (Q30925847) (← links)
• The applicability of in vitro-derived data in hazard identification and characterisation of chemicals (Q33969320) (← links)
• Potential new therapeutic modality revealed through agent-based modeling of the neuromuscular junction and acetylcholinesterase inhibition (Q34401947) (← links)
• Methods of in vitro toxicology (Q34563173) (← links)
• Discovery of New Classes of Compounds that Reactivate Acetylcholinesterase Inhibited by Organophosphates (Q36331614) (← links)
• Data-derived safety factors for the evaluation of food additives and environmental contaminants (Q36767849) (← links)
• Approaches for applications of physiologically based pharmacokinetic models in risk assessment (Q37201545) (← links)
• Toxicokinetics of soman: species variation and stereospecificity in elimination pathways (Q37762579) (← links)
• Physiologically based pharmacokinetics of molecular imaging nanoparticles for mRNA detection determined in tumor-bearing mice. (Q38344721) (← links)
• Systems Pharmacology Approach for Prediction of Pulmonary and Systemic Pharmacokinetics and Receptor Occupancy of Inhaled Drugs (Q40258577) (← links)
• Physiologically-based pharmacokinetic modeling and bioactivation of xenobiotics (Q40419495) (← links)
• The design and fabrication of three-chamber microscale cell culture analog devices with integrated dissolved oxygen sensors (Q40592433) (← links)
• Coupling toxicokinetics and pharmacodynamics for predicting survival of abalone (Haliotis diversicolor supertexta) exposed to waterborne zinc (Q40632625) (← links)
• Perspectives in pharmacokinetics. Physiologically based pharmacokinetic modeling as a tool for drug development (Q41041971) (← links)
• Serum acetyl cholinesterase as a biomarker of arsenic induced neurotoxicity in sprague-dawley rats (Q41859061) (← links)
• Incorporation of 3T3-L1 cells to mimic bioaccumulation in a microscale cell culture analog device for toxicity studies (Q42830112) (← links)
• Sensitivity analysis on a physiologically-based pharmacokinetic and pharmacodynamic model for diisopropylfluorophosphate-induced toxicity in mice and rats (Q43269698) (← links)
• Biological targets of neurotoxic pesticides analysed by alteration of developmental events in the Mediterranean sea urchin, Paracentrotus lividus (Q44241031) (← links)
• Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling (Q44659380) (← links)
• Quantitative Structure–Activity Relationships for Organophosphates Binding to Trypsin and Chymotrypsin (Q44763351) (← links)
• A human life-stage physiologically based pharmacokinetic and pharmacodynamic model for chlorpyrifos: development and validation (Q44804848) (← links)
• Bayesian calibration of a physiologically based pharmacokinetic/pharmacodynamic model of carbaryl cholinesterase inhibition (Q46163078) (← links)
• Reconstructing exposures from small samples using physiologically based pharmacokinetic models and multiple biomarkers (Q46609020) (← links)
• Chronic, low-level exposure to the cholinesterase inhibitor DFP. I. Time course of neurochemical changes in the rat pontomesencephalic tegmentum (Q48107878) (← links)
• A Physiologically Based Pharmacokinetic and Pharmacodynamic Model for Paraoxon in Rainbow Trout (Q48673095) (← links)
• Modeling Kinetic Interactions of Chemical Mixtures (Q57382869) (← links)
• A preliminary physiologically based pharmacokinetic model for naphthalene and naphthalene oxide in mice and rats (Q71182301) (← links)
• Acute toxicity modeling of rainbow trout and silver sea bream exposed to waterborne metals (Q74386342) (← links)
• The use of information on susceptibility in risk assessment: state of the science and potential for improvement (Q84586274) (← links)